These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 709557)

  • 21. Phase I--II evaluation of combination cyclophosphamide, 5-fluorouracil, hexamethylmelamine, and prednisone in advanced breast cancer.
    Chang YC; Falkson G; Tormey DC; Crowley J
    Cancer Clin Trials; 1981; 4(4):377-80. PubMed ID: 6797746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II trial of a combination of vinorelbine, cyclophosphamide and 5-fluorouracil in the treatment of advanced breast cancer.
    Ardavanis A; Extra JM; Espié M; Cuvier C; Marty M
    In Vivo; 1998; 12(5):559-62. PubMed ID: 9827368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
    Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
    Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.
    Ribas A; Albanell J; Solé-Calvo LA; Gallardo E; Bellmunt J; Vera R; Vidal R; Carulla J; Baselga J
    Cancer; 1998 Mar; 82(5):878-85. PubMed ID: 9486577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective, randomized Phase III trial comparing combination chemotherapy with cyclophosphamide, doxorubicin, and 5-fluorouracil with vinorelbine plus doxorubicin in the treatment of advanced breast carcinoma.
    Blajman C; Balbiani L; Block J; Coppola F; Chacon R; Fein L; Bonicatto S; Alvarez A; Schmilovich A; Delgado FM
    Cancer; 1999 Mar; 85(5):1091-7. PubMed ID: 10091793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
    Weiss RB; Woolf SH; Demakos E; Holland JF; Berry DA; Falkson G; Cirrincione CT; Robbins A; Bothun S; Henderson IC; Norton L;
    J Clin Oncol; 2003 May; 21(9):1825-35. PubMed ID: 12721260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combination chemotherapy in metastatic breast cancer].
    Kuten A; Lev L; Mohaliver J; Robinson E
    Harefuah; 1981 Feb; 100(3):118-20. PubMed ID: 7262675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doxorubicin, mitolactol (dibromodulcitol), and mitomycin C treatment for patients with metastatic breast cancer previously treated with cyclophosphamide, methotrexate, 5-FU, vincristine, and prednisone (CMFVP).
    DiStefano A; Yap HY; Blumenschein GR
    Cancer Treat Rep; 1981; 65(1-2):33-8. PubMed ID: 7013977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential continuous infusion with doxorubicin and vinblastine: an effective chemotherapy combination for patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate, 5-FU, vincristine, and prednisone.
    Tannir N; Yap HY; Hortobagyi GH; Hug V; Buzdar AU; Blumenschein GR
    Cancer Treat Rep; 1984; 68(7-8):1039-41. PubMed ID: 6547638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer].
    Abe O; Izuo M; Enomoto K; Kubo K; Koyama H; Sakai K; Terasawa T; Tominaga T; Nomura Y
    Gan To Kagaku Ryoho; 1982 May; 9(5):866-73. PubMed ID: 7184431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination chemotherapy in advanced breast cancer. A report of the Working Party of the Multicentre Cancer Chemotherapy Group.
    Spittle MF; Bates TD; Kitchen G; Nicol NT; Wheeler T; Edelstyn G; MacRae KD; Ostrowski MJ
    Clin Oncol; 1980 Jun; 6(2):153-7. PubMed ID: 7408282
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of metastasising soft-tissue sarcoma with a uniform combination chemotherapy of cyclosphosphamide, vincristin, adriamycin and DTIC ("CyVADIC") (author's transl)].
    Schmidt M; Sodomann CP; Gropp C; Havemann K
    Dtsch Med Wochenschr; 1978 Jul; 103(30):1206-10. PubMed ID: 668561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II study of alternating cytoreductive and cycle-active combination chemotherapy for metastatic breast cancer.
    Vogel CL; Love NH; East DR; Moore MR; Smalley RV
    Cancer Treat Rep; 1979; 63(11-12):2077-9. PubMed ID: 526940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metastatic sarcomas: chemotherapy with adriamycin, cyclophosphamide, and methotrexate alternating with actinomycin D, DTIC, and vincristine.
    Presant CA; Lowenbraun S; Bartolucci AA; Smalley RV
    Cancer; 1981 Feb; 47(3):457-65. PubMed ID: 7225999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dilemma regarding postoperative chemotherapy in primary carcinoma of the colon.
    Weiss RB; DeVita VT
    Surg Gynecol Obstet; 1979 Aug; 149(2):267-71. PubMed ID: 380029
    [No Abstract]   [Full Text] [Related]  

  • 36. Potentiation of anticancer agent cytotoxicity against sensitive and resistant AKR leukemia by amphotericin B1.
    Valeriote F; Medoff G; Dieckman J
    Cancer Res; 1979 Jun; 39(6 Pt 1):2041-5. PubMed ID: 445402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Results of a cytostatic combination treatment of metastasized breast and small cell bronchial carcinoma during partial blockade of the cell cycle].
    Ammon J; Kreidler J; Goronzy J
    Strahlentherapie Sonderb; 1978; 75():126-33. PubMed ID: 233454
    [No Abstract]   [Full Text] [Related]  

  • 38. Combination of adriamycin and cyclophosphamide in the treatment of metastatic prostatic carcinoma: a phase II study.
    Izbicki RM; Amer MH; Al-Sarraf M
    Cancer Treat Rep; 1979 Jun; 63(6):999-1001. PubMed ID: 380805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Five-drug therapy in addition to hormonal treatment in advance breast cancer metastatic to the lung (author's transl)].
    Matthiessen W; Pochhammer KF
    Prax Pneumol; 1976 Aug; 30(8):479-8. PubMed ID: 959156
    [No Abstract]   [Full Text] [Related]  

  • 40. Cyclophosphamide, vincristine, adriamycin, and dimethyl-triazeno imidazole carboxamide (CYVADIC) for sarcomas of the female genital tract.
    Piver MS; DeEulis TG; Lele SB; Barlow JJ
    Gynecol Oncol; 1982 Dec; 14(3):319-23. PubMed ID: 6897542
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.